相似文献
1
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022.
Breast Care (Basel). 2022 Aug;17(4):421-429. doi: 10.1159/000524789. Epub 2022 May 2.
2
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024.
Breast Care (Basel). 2024 Jun;19(3):183-191. doi: 10.1159/000538753. Epub 2024 Apr 10.
3
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023.
Breast Care (Basel). 2023 Aug;18(4):306-315. doi: 10.1159/000531579. Epub 2023 Jun 16.
4
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019.
Breast Care (Basel). 2019 Aug;14(4):247-255. doi: 10.1159/000500999. Epub 2019 Jul 30.
5
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.
Breast Care (Basel). 2024 Jun;19(3):165-182. doi: 10.1159/000538596. Epub 2024 Apr 18.
6
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023.
Breast Care (Basel). 2023 Aug;18(4):289-305. doi: 10.1159/000531578. Epub 2023 Jun 16.
7
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.
Breast Care (Basel). 2022 Aug;17(4):403-420. doi: 10.1159/000524879. Epub 2022 May 5.
8
ABC7 Consensus: Assessment by a German Group of Experts.
Breast Care (Basel). 2024 Apr;19(2):116-128. doi: 10.1159/000535997. Epub 2024 Jan 24.
9
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2018.
Breast Care (Basel). 2018 Jul;13(3):196-208. doi: 10.1159/000489329. Epub 2018 Jun 15.
10
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts.
Breast Care (Basel). 2020 Feb;15(1):82-95. doi: 10.1159/000505957. Epub 2020 Feb 10.
引用本文的文献
1
Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays-results of the TARGIT BQR prospective phase IV trial.
Strahlenther Onkol. 2025 May 19. doi: 10.1007/s00066-025-02412-0.
2
Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy.
Sci Rep. 2025 Mar 25;15(1):10347. doi: 10.1038/s41598-025-95114-7.
3
Prognostic Factors in Therapy Regimes of Breast Cancer Patients with Brain Metastases: A Retrospective Monocentric Analysis.
Cancers (Basel). 2025 Jan 15;17(2):261. doi: 10.3390/cancers17020261.
4
Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records.
Breast Cancer Res Treat. 2025 Jan;209(2):419-430. doi: 10.1007/s10549-024-07506-4. Epub 2024 Oct 20.
5
Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer-Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR).
Cancers (Basel). 2024 May 30;16(11):2067. doi: 10.3390/cancers16112067.
6
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer.
BMC Cancer. 2024 May 24;24(1):641. doi: 10.1186/s12885-024-12179-9.
7
Metastatic Breast Cancer: Prolonging Life in Routine Oncology Care.
Cancers (Basel). 2024 Mar 22;16(7):1255. doi: 10.3390/cancers16071255.
8
Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole: a case report and literature review.
Front Oncol. 2024 Jan 23;14:1286910. doi: 10.3389/fonc.2024.1286910. eCollection 2024.
9
Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancer.
Sci Rep. 2023 Dec 2;13(1):21262. doi: 10.1038/s41598-023-47874-3.
10
Narrative Review of Multidisciplinary Management of Central Nervous Involvement in Patients with HER2-Positive Metastatic Breast Cancer: Focus on Elderly Patients.
Adv Ther. 2023 Aug;40(8):3304-3331. doi: 10.1007/s12325-023-02538-6. Epub 2023 Jun 8.
本文引用的文献
1
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022.
2
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
N Engl J Med. 2022 Mar 10;386(10):942-950. doi: 10.1056/NEJMoa2114663.
3
Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial.
J Am Coll Surg. 2021 Dec;233(6):742-751.e5. doi: 10.1016/j.jamcollsurg.2021.08.686. Epub 2021 Sep 13.
4
Pathogenic DPYD Variants and Treatment-Related Mortality in Patients Receiving Fluoropyrimidine Chemotherapy: A Systematic Review and Meta-Analysis.
Oncologist. 2021 Dec;26(12):1008-1016. doi: 10.1002/onco.13967. Epub 2021 Sep 29.
5
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.
Ann Oncol. 2021 Nov;32(11):1332-1347. doi: 10.1016/j.annonc.2021.07.016. Epub 2021 Aug 6.
6
Contralateral Axillary Nodal Metastases: Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?
Ann Surg Oncol. 2021 Oct;28(10):5544-5552. doi: 10.1245/s10434-021-10461-9. Epub 2021 Jul 21.
7
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.
Ann Oncol. 2021 Aug;32(8):994-1004. doi: 10.1016/j.annonc.2021.05.801. Epub 2021 Jul 1.
8
PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer.
Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD011395. doi: 10.1002/14651858.CD011395.pub2.
9
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485.
10
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study.
Ann Surg Oncol. 2021 Sep;28(9):5048-5057. doi: 10.1245/s10434-021-09621-8. Epub 2021 Feb 2.
Zotero 插件